SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition

From National Research Council Canada

Download
  1. (PDF, 1.1 MiB)
  2. (PDF, 76 KiB)
  3. (PDF, 431 KiB)
  4. (XLSX, 30 KiB)
DOIResolve DOI: https://doi.org/10.3389/fimmu.2023.1223936
AuthorSearch for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: 1ORCID identifier: https://orcid.org/0000-0002-2268-4111; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for: ; Search for:
Affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText, Article
Subjectpost covid condition (PCC); long covid; anti-RBD antibody titer; RBD specific B cells; SARS-CoV-2 infection
Abstract
Publication date
PublisherFrontiers Media SA
Licence
In
LanguageEnglish
Peer reviewedYes
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifier1b8a8bd7-89e8-4457-9355-77b1b4f00fb7
Record created2024-07-24
Record modified2024-07-24
Date modified: